These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38158229)
1. Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality. Pyka Ł; Hudzik B; Bartuś S; Buszman P; Gierlotka M; Wojakowski W; Hiczkiewicz J; Kleinrok A; Skrzypek M; Kuliczkowski W; Gąsior M J Cardiovasc Pharmacol Ther; 2023; 28():10742484231212106. PubMed ID: 38158229 [TBL] [Abstract][Full Text] [Related]
2. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study]. Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427 [No Abstract] [Full Text] [Related]
3. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244 [TBL] [Abstract][Full Text] [Related]
4. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events. Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG; Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742 [TBL] [Abstract][Full Text] [Related]
5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
6. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK; Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy. Lucà F; Caretta G; Vagnarelli F; Marini M; Iorio A; Di Fusco SA; Pozzi A; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):99-105. PubMed ID: 31923052 [TBL] [Abstract][Full Text] [Related]
8. Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial. Jackson LR; Piccini JP; Cyr DD; Roe MT; Neely ML; Martinez F; Lüscher TF; Lopes RD; Winters KJ; White HD; Armstrong PW; Fox KA; Prabhakaran D; Bhatt DL; Magnus Ohman E; Corbalán R Clin Cardiol; 2016 Sep; 39(9):497-506. PubMed ID: 27468086 [TBL] [Abstract][Full Text] [Related]
9. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. RAF and RENO-EXTEND Investigators* Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U; Lindbäck J; Wallentin L; Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355 [TBL] [Abstract][Full Text] [Related]
11. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review. Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA; Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057 [TBL] [Abstract][Full Text] [Related]
12. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry. Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277 [TBL] [Abstract][Full Text] [Related]
14. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242 [TBL] [Abstract][Full Text] [Related]
15. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Fanaroff AC; Lopes RD Prog Cardiovasc Dis; 2021; 69():11-17. PubMed ID: 34883097 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk? Fake AL; Harding SA; Matsis PP; Larsen PD N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167 [TBL] [Abstract][Full Text] [Related]
17. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822 [TBL] [Abstract][Full Text] [Related]
18. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED; Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512 [TBL] [Abstract][Full Text] [Related]
19. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry. Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F; J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes. Bor WLW; Azzahhafi J; Maio ND; van der Sangen NMR; Verburg A; Rayhi S; Peper J; Chan Pin Yin DRPP; Ten Berg JM EuroIntervention; 2024 Aug; 20(16):996-1007. PubMed ID: 39155759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]